Related Experiment Video
Updated: Aug 11, 2026
09:21
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Constitutional balanced translocations in alveolar rhabdomyosarcoma
S Savaşan1, A Lorenzana, J A Williams
1Department of Pathology and Laboratory Medicine, Barbara Ann Karmanos Cancer Institute and Children's Hospital of Michigan, Detroit, USA.
Cancer Genetics and Cytogenetics
|August 5, 1998
Summary
Two children with alveolar rhabdomyosarcoma had specific chromosomal translocations, t(1;5) and t(1;22), present in both tumor and blood cells. These translocations were either inherited or de novo, potentially contributing to rhabdomyosarcoma development.
Area of Science:
- Cytogenetics
- Pediatric Oncology
- Cancer Genetics
Background:
- Alveolar rhabdomyosarcoma is a rare and aggressive pediatric soft tissue sarcoma.
- Cytogenetic abnormalities, particularly translocations, are known to play a role in the pathogenesis of various cancers, including rhabdomyosarcoma.
Observation:
- Tumor tissue analysis from two children with alveolar rhabdomyosarcoma revealed distinct chromosomal translocations: t(1;5)(q32;q31) and t(1;22)(q21;q11.2).
- These specific translocations were consistently observed in all examined metaphases of tumor cells.
- Peripheral blood lymphocytes from both patients also carried the identical cytogenetic abnormalities found in their tumor cells.
Findings:
- The translocation t(1;22) was identified as a de novo constitutional translocation in one patient, as parental lymphocytes were karyotypically normal.
- The translocation t(1;5) was found to be paternally inherited in the other patient.
- The presence of these constitutional translocations in both pediatric patients suggests a potential genetic predisposition or contribution to alveolar rhabdomyosarcoma development.
Implications:
- Identifying constitutional translocations in pediatric alveolar rhabdomyosarcoma patients can offer insights into disease etiology.
- These findings may inform future genetic counseling and risk assessment for families affected by rhabdomyosarcoma.
- Further research into the role of these specific translocations in rhabdomyosarcoma pathogenesis is warranted.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...